Advanced

Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy.

Niméus, Emma LU ; Malmström, Johan LU ; Johnsson, Anders LU ; Marko-Varga, György LU and Fernö, Mårten LU (2007) In Journal of Pharmaceutical and Biomedical Analysis 43(3). p.1086-1093
Abstract
Breast cancer is a heterogenous disease and it is of importance to select patients with regard to different prognosis and treatment sensitivity to individualize treatment regimes. In this study we successfully adapted a protein extraction protocol from mRNA extracted tumor samples enabling two-dimensional gel electrophoresis (2-DE) analysis of samples previously analyzed by cDNA microarray. The aim was to find candidate proteins that distinguish breast cancer patients with or without recurrences after adjuvant CMF (cyclophosphamide, methotrexate and 5-FU) treatment within four years to follow-up. We identified several proteins distinguishing the recurrence group from the non-recurrence group, especially in the ER and PgR positive subgroup... (More)
Breast cancer is a heterogenous disease and it is of importance to select patients with regard to different prognosis and treatment sensitivity to individualize treatment regimes. In this study we successfully adapted a protein extraction protocol from mRNA extracted tumor samples enabling two-dimensional gel electrophoresis (2-DE) analysis of samples previously analyzed by cDNA microarray. The aim was to find candidate proteins that distinguish breast cancer patients with or without recurrences after adjuvant CMF (cyclophosphamide, methotrexate and 5-FU) treatment within four years to follow-up. We identified several proteins distinguishing the recurrence group from the non-recurrence group, especially in the ER and PgR positive subgroup (n = 7). The induced proteins were involved in translation/folding, iron ion binding, and protease inhibition, whereas proteins involved in signaling, ubiquitination, and splicing were decreased in expression. These results show that it is possible to use 2-DE to separate high abundant proteins in breast cancer tissue and to find discriminating proteins to identify patients with different prognosis after adjuvant CMF treatment. (Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
drug resistance, breast cancer, prognostic markers, two-dimensional gel electrophoresis
in
Journal of Pharmaceutical and Biomedical Analysis
volume
43
issue
3
pages
1086 - 1093
publisher
Elsevier
external identifiers
  • wos:000244623000040
  • scopus:33846593395
  • pmid:17085005
ISSN
0731-7085
DOI
10.1016/j.jpba.2006.09.019
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Analytical Chemistry (S/LTH) (011001004), Division V (013230900), Department of Experimental Medical Science (013210000), Oncology, MV (013035000), Lung Biology (013212002)
id
ca1accd0-43aa-44f8-8fa7-d776f495f06e (old id 163421)
date added to LUP
2016-04-01 11:54:00
date last changed
2021-01-06 08:55:29
@article{ca1accd0-43aa-44f8-8fa7-d776f495f06e,
  abstract     = {Breast cancer is a heterogenous disease and it is of importance to select patients with regard to different prognosis and treatment sensitivity to individualize treatment regimes. In this study we successfully adapted a protein extraction protocol from mRNA extracted tumor samples enabling two-dimensional gel electrophoresis (2-DE) analysis of samples previously analyzed by cDNA microarray. The aim was to find candidate proteins that distinguish breast cancer patients with or without recurrences after adjuvant CMF (cyclophosphamide, methotrexate and 5-FU) treatment within four years to follow-up. We identified several proteins distinguishing the recurrence group from the non-recurrence group, especially in the ER and PgR positive subgroup (n = 7). The induced proteins were involved in translation/folding, iron ion binding, and protease inhibition, whereas proteins involved in signaling, ubiquitination, and splicing were decreased in expression. These results show that it is possible to use 2-DE to separate high abundant proteins in breast cancer tissue and to find discriminating proteins to identify patients with different prognosis after adjuvant CMF treatment.},
  author       = {Niméus, Emma and Malmström, Johan and Johnsson, Anders and Marko-Varga, György and Fernö, Mårten},
  issn         = {0731-7085},
  language     = {eng},
  number       = {3},
  pages        = {1086--1093},
  publisher    = {Elsevier},
  series       = {Journal of Pharmaceutical and Biomedical Analysis},
  title        = {Proteomic analysis identifies candidate proteins associated with distant recurrences in breast cancer after adjuvant chemotherapy.},
  url          = {http://dx.doi.org/10.1016/j.jpba.2006.09.019},
  doi          = {10.1016/j.jpba.2006.09.019},
  volume       = {43},
  year         = {2007},
}